<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">FTB</journal-id>
<journal-id journal-id-type="nlm-ta">Food Technol Biotechnol</journal-id>
<journal-title-group>
<journal-title>Food Technology and Biotechnology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Food Technol. Biotechnol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1330-9862</issn>
<issn pub-type="epub">1334-2606</issn>
<publisher><publisher-name>University of Zagreb Faculty of Food Technology and Biotechnology</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">FTB-64-20</article-id>
<article-id pub-id-type="doi">10.17113/ftb.64.01.26.9074</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Original scientific papers</subject></subj-group>
</article-categories>
<title-group>
<article-title>Autochthonous Human Milk <italic>Lactobacillus</italic> Strains as Potential Probiotic Starter Cultures</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1682-0703</contrib-id><name><surname>Butorac</surname><given-names>Katarina</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0509-8284</contrib-id><name><surname>Bani&#x0107;</surname><given-names>Martina</given-names></name></contrib><contrib contrib-type="author"><name><surname>El Khalifa</surname><given-names>Dina</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-9199-3582</contrib-id><name><surname>Habu&#x0161;</surname><given-names>Ena</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7565-8910</contrib-id><name><surname>&#x010C;uljak</surname><given-names>Nina</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4954-7133</contrib-id><name><surname>Lebo&#x0161; Pavunc</surname><given-names>Andreja</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1374-1097</contrib-id><name><surname>Novak</surname><given-names>Jasna</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9790-3008</contrib-id><name><surname>&#x0160;u&#x0161;kovi&#x0107;</surname><given-names>Jagoda</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1711-316X</contrib-id><name><surname>Kos</surname><given-names>Bla&#x017E;enka</given-names></name></contrib>
<aff id="aff1"><institution content-type="dept">Laboratory for Antibiotic, Enzyme, Probiotic and Starter Cultures Technology</institution>, <institution>University of Zagreb Faculty of Food Technology and Biotechnology</institution>, <addr-line>Pierottijeva 6</addr-line>, <addr-line>10000 Zagreb</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Corresponding author: Phone: +38514605125, E-mail: <email xlink:href="martina.banic@pbf.unizg.hr">martina.banic@pbf.unizg.hr</email></corresp>
<fn fn-type="con">
<p content-type="fn-title">AUTHORS&apos; CONTRIBUTION</p>
<p>K. Butorac performed the analysis of proteolytic and antioxidant activity, drafted the article, designed the work, and carried out the graphical presentation, data analysis and interpretation. M. Bani&#x0107; collected and identified the lactic acid bacteria strains, performed the analysis of antimicrobial activity and freeze-drying, drafted the article, and contributed to data analysis and interpretation. B. Kos supervised the work, critically revised the manuscript and approved the final version to be published. N. &#x010C;uljak participated in the statistical analysis of the results and preparation of the manuscript. D. El Khalifa performed the analysis of antimicrobial and antioxidant activity. E. Habu&#x0161; performed the analysis of proteolytic activity. A. Lebo&#x0161; Pavunc and J. Novak were involved in the preparation and critical revision of the manuscript. J. &#x0160;u&#x0161;kovi&#x0107; approved the final version to be published. All authors approved the final version of the manuscript for publication.</p>
</fn>
</author-notes>
<pub-date date-type="pub" publication-format="electronic"><day>15</day><month>02</month><year>2026</year></pub-date>
<pub-date date-type="pub" publication-format="print"><season>Jan-Mar</season><year>2026</year></pub-date>
<volume>64</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>29</lpage>
<history>
<date date-type="received"><day>13</day><month>02</month><year>2025</year></date>
<date date-type="accepted"><day>25</day><month>07</month><year>2025</year></date>
</history>
<permissions>
<copyright-statement>2026 Authors retain copyright and grant the FTB journal the right of first publication under CC-BY 4.0 licence that allows others to share the work with an acknowledgment of the authorship and initial publication in the journal</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>2026 Authors retain copyright and grant the FTB journal the right of first publication under CC-BY 4.0 licence that allows others to share the work with an acknowledgment of the authorship and initial publication in the journal</copyright-holder>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/" specific-use="CC BY 4.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license>
</permissions>
<abstract>
<title>SUMMARY</title>
<sec><title>Research background</title><p>Human milk is rich in bioactive molecules and beneficial bacteria that contribute to shaping the newborn&apos;s microbiota. In this study, we aim to evaluate lactic acid bacteria strains isolated from human milk of healthy Croatian women as potential functional starter cultures.</p></sec>
<sec><title>Experimental approach</title><p>In order to define novel potential probiotics for use in dairy products, eight strains of lactobacilli were analysed for their proteolytic, antimicrobial and antioxidant activity as well as their survival rate during freeze-drying.</p></sec>
<sec><title>Results and conclusions</title><p>Based on the results obtained, the exopolysaccharide-producing <italic>Limosilactobacillus fermentum</italic> MC1, the surface (S)-layer-producing <italic>Levilactobacillus brevis</italic> MB2 and the plantaricin-producing <italic>Lactiplantibacillus plantarum</italic> MB18 strains are candidates for the production of fermented dairy products with potential functional and nutritional relevance for the host. The selected strains exerted high casein degradation capacity, a broad spectrum of antimicrobial activity and a promising 2,2-diphenyl-1-picrylhydrazyl hydrate radical scavenging activity. They also fulfilled the primary technological criterion by having a high survival rate during freeze-drying.</p></sec>
<sec><title>Novelty and scientific contribution</title><p>The data presented emphasise the importance of human milk as a valuable source of lactic acid bacteria with unique technological and functional properties, which are important both as a basis for scientific research and for the development of novel starter cultures for functional products.</p></sec>
</abstract>
<kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>human milk</kwd><kwd>microbiota</kwd><kwd>functional starter cultures</kwd><kwd>lactic acid bacteria</kwd></kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>INTRODUCTION</title>
<p>Human milk is a source of numerous bioactive molecules that are crucial for the protection and development of the infant. Although it was originally considered sterile, accumulating evidence suggests that it comprises not only biomolecules but also the human milk microbiota, which is of great importance as its disruption, particularly in early childhood, may underlie the development of certain diseases (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>). Lactic acid bacteria (LAB) with probiotic properties have been isolated from many different sources, but those from human milk are considered valuable because of their human origin and safety for infants (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>). The most abundant bacterial species in the human milk microbiota belong to the genera <italic>Staphylococcus, Streptococcus, Lactobacillus, Pseudomonas, Corynebacterium, Bifidobacterium, Enterococcus, Rothia, Acinetobacter, Veillonella, Cutibacterium</italic> and <italic>Bacteroides</italic> (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>, <xref ref-type="bibr" rid="r4"><italic>4</italic></xref>). <italic>Lactobacillus</italic> strains, especially those isolated from fermented milk products, have a highly efficient proteolytic system which ensures self-sufficiency in free amino acids, but is also important for the production of casein-derived bioactive peptides (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r6"><italic>6</italic></xref>). Various LAB strains show antagonistic activity against certain pathogenic microorganisms, which is often attributed to two mechanisms of action (<xref ref-type="bibr" rid="r7"><italic>7</italic></xref>). Firstly, LAB produce organic acids through fermentation, which lowers the pH of the environment and prevents the survival of some pathogens that are intolerable to acidic conditions (<xref ref-type="bibr" rid="r8"><italic>8</italic></xref>). Secondly, LAB can produce bacteriocins, polypeptides that inhibit certain foodborne pathogens and harmful bacteria such as <italic>Escherichia coli</italic>, <italic>Staphylococcus</italic>, <italic>Salmonella</italic> and <italic>Listeria monocytogenes</italic> (<xref ref-type="bibr" rid="r9"><italic>9</italic></xref>, <xref ref-type="bibr" rid="r10"><italic>10</italic></xref>). LAB can also produce surface (S)-layer proteins on their cell surface, which play an important role in the probiotic properties of the producer strain, such as protection against unfavourable environmental conditions, aggregation capacity and adhesion (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). Exopolysaccharides (EPSs), high molecular mass carbohydrate polymers, also contribute to the probiotic properties of LAB by favourably influencing their survival during freeze-drying, adherence to human epithelial cells and competitive exclusion of pathogens (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>).</p>
<p>Numerous health issues such as diabetes, cancer and cardiovascular, neurological and inflammatory disorders are associated with oxidative stress. Probiotics have garnered growing scientific attention due to the ongoing search for natural antioxidants. Although various LAB strains are currently used in numerous dietary supplements, their antioxidant effects are still relatively poorly understood (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>). For these reasons, LAB with desirable probiotic properties are being used to develop functional beverages that can improve the health of the gastrointestinal tract of consumers by preventing the proliferation of pathogens and activating the immune system (<xref ref-type="bibr" rid="r14"><italic>14</italic></xref>). Some probiotic strains of lactobacilli and bifidobacteria are frequently used as starter and co-starter cultures for the production of various functional products. They tolerate the low pH of products such as fermented milk during fermentation and cold storage (<xref ref-type="bibr" rid="r15"><italic>15</italic></xref>). Therefore, this work focuses on the selection of proteinase-producing, antimicrobial and antioxidant LAB strains previously isolated from the human milk microbiota (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>) and characterised as potential probiotics (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>, <xref ref-type="bibr" rid="r12"><italic>12</italic></xref>) to be utilised as functional starter cultures in the production of probiotic products.</p>
</sec>
<sec sec-type="materials|methods">
<title>MATERIALS AND METHODS</title>
<sec>
<title>Bacterial strains and cultivation conditions</title>
<p>The bacterial strains analysed in this study are deposited in the Culture Collection of the Laboratory for Antibiotic, Enzyme, Probiotic and Starter Cultures Technology, University of Zagreb Faculty of Food Technology and Biotechnology, Zagreb, Croatia. The strains were stored as frozen stocks at -80 &#x00B0;C in a CryoCube F101h ultra-low temperature freezer (Eppendorf, Hamburg, Germany) (<xref ref-type="table" rid="t1">Table 1</xref> (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>, <xref ref-type="bibr" rid="r16"><italic>16</italic></xref>)), in de Man-Rogosa-Sharpe (MRS; Difco, Detroit, MI, USA) broth for lactobacilli, M17 broth (Biolife, Milan, Italy) for lactococci and enterococci and nutrient broth (Biolife) for test microorganisms, supplemented with <italic>&#x03C6;</italic>(glycerol)=15 % (Sigma-Aldrich, Merck, St Louis, MO, USA). Before every experimental trial, each strain was subcultured twice in a suitable growth medium under the listed growth conditions.</p>
<table-wrap id="t1" position="float">
<label>Table 1</label><caption><title>Bacterial strains used in this study and their cultivation conditions</title>
</caption>
<table frame="hsides" rules="groups">
<col width="34.42%"/>
<col width="23.44%"/>
<col width="13.88%"/>
<col width="28.26%"/>
<thead>
<tr>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">Bacterial strain</th>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">Cultivation conditions</th>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">Origin</th>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">Bioactive molecule production [reference]</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Lactiplantibacillus</italic><break/><italic>plantarum</italic> KR19</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">bacteriocin (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Limosilactobacillus fermentum</italic> MC1</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">exopolysaccharide (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Lactiplantibacillus</italic><break/><italic>plantarum</italic> MC19</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">bacteriocin (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Levilactobacillus</italic><break/><italic>brevis</italic> MB1</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">S-protein (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Levilactobacillus</italic><break/><italic>brevis</italic> MB2</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">S-protein (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Levilactobacillus</italic><break/><italic>brevis</italic> MB13</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">S-protein (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Lactiplantibacillus</italic><break/><italic>plantarum</italic> MB18</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">bacteriocin (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Levilactobacillus</italic><break/><italic>brevis</italic> MB20</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">human milk</td>
<td valign="middle" align="center">S-protein (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Lactobacillus</italic><break/><italic>helveticus</italic> M92</td>
<td valign="middle" align="center">MRS, 37 &#x00B0;C, microaerophilic*</td>
<td valign="middle" align="center">fermented milk</td>
<td valign="middle" align="center">S-protein (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Lactococcus lactis</italic> ssp. <italic>lactis</italic> LMG 9450</td>
<td valign="middle" align="center">M17, 30 &#x00B0;C, aerobic</td>
<td valign="middle" align="center">BCCM</td>
<td valign="middle" align="center">/</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Enterococcus faecium</italic> ATCC<sup>&#x00AE;</sup>9430<sup>&#x2122;</sup></td>
<td valign="middle" align="center">M17, 37 &#x00B0;C, aerobic</td>
<td valign="middle" align="center">ATCC</td>
<td valign="middle" align="center">/</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Staphylococcus aureus</italic> ATCC<sup>&#x00AE;</sup>25925<sup>&#x2122;</sup></td>
<td valign="middle" align="center">nutrient broth, 37 &#x00B0;C, aerobic</td>
<td valign="middle" align="center">ATCC</td>
<td valign="middle" align="center">/</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Listeria monocytogenes</italic> ATCC<sup>&#x00AE;</sup>19111<sup>&#x2122;</sup></td>
<td valign="middle" align="center">nutrient broth, 37 &#x00B0;C, aerobic</td>
<td valign="middle" align="center">ATCC</td>
<td valign="middle" align="center">/</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>Escherichia coli</italic> ATCC<sup>&#x00AE;</sup>25922<sup>&#x2122;</sup></td>
<td valign="middle" align="center">nutrient broth, 37 &#x00B0;C, aerobic</td>
<td valign="middle" align="center">ATCC</td>
<td valign="middle" align="center">/</td>
</tr>
<tr>
<td valign="middle" align="justify" style="border-bottom: solid 0.50pt" scope="row"><italic>Salmonella enterica</italic> serovar Typhimurium ATCC<sup>&#x00AE;</sup>14028<sup>&#x2122;</sup></td>
<td valign="middle" align="center" style="border-bottom: solid 0.50pt">nutrient broth, 37 &#x00B0;C, aerobic</td>
<td valign="middle" align="center" style="border-bottom: solid 0.50pt">ATCC</td>
<td valign="middle" align="center" style="border-bottom: solid 0.50pt">/</td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>*Microaerophilic conditions were created using Anaerocult A system (Merck, Darmstadt, Germany). BCCM=Belgian Coordinated Collections of Microorganisms, ATCC=American Type Culture Collection</p>
</table-wrap-foot></table-wrap>
</sec>
<sec>
<title>Antimicrobial activity</title>
<p>The antimicrobial activity of the LAB strains against test microorganisms and related LAB was determined using the turbidimetric method according to Lebo&#x0161; Pavunc <italic>et al</italic>. (<xref ref-type="bibr" rid="r17"><italic>17</italic></xref>) with slight modifications. The supernatant of overnight cultures of LAB strains isolated from human milk was filtered using sterile filter (Sigma-Aldrich, Merck) with a diameter of 0.2 &#x03BC;m, and the filtrate was used in the experiment.</p>
<p>The antimicrobial activity of the selected LAB isolates from human milk was tested against test microorganisms (<italic>Staphylococcus aureus</italic> ATCC<sup>&#x00AE;</sup>25925<sup>&#x2122;</sup>, <italic>Listeria monocytogenes</italic> ATCC<sup>&#x00AE;</sup>19111<sup>&#x2122;</sup>, <italic>Escherichia coli</italic> ATCC<sup>&#x00AE;</sup>25922<sup>&#x2122;</sup> and <italic>Salmonella</italic> Typhimurium FP1) and related LAB strains (<italic>Lactobacillus helveticus</italic> M92, <italic>L. lactis</italic> ssp. <italic>lactis</italic> LMG 9450 and <italic>Enterococcus faecium</italic> ATCC<sup>&#x00AE;</sup>9430<sup>&#x2122;</sup>) cultured in the appropriate medium until their <italic>A</italic><sub>620 nm</sub> reached 0.5 and 1.0, respectively. A volume of 10 &#x00B5;L of overnight cultures of the test microorganisms or related LAB strains was added to the wells of the microtitre plate (Greiner Bio-One, Kremsm&#x00FC;nster, Austria) together with 90 &#x00B5;L of a suitable cultivation medium and 100 &#x00B5;L of culture supernatants of selected LAB isolates from human milk. A volume of 10 &#x00B5;L of a culture of a specific test microorganism or a related LAB grown in 190 &#x00B5;L of the suitable cultivation medium was used as a control. The antibacterial activity of the culture supernatant was determined after 24 h at 37 &#x00B0;C by spectrophotometric measurement of the apparent absorbance at a wavelength of 620 nm using a microtitre plate reader Infinite F Plex (Tecan, M&#x00E4;nnedorf, Switzerland).</p>
</sec>
<sec>
<title>Proteolytic activity</title>
<sec>
<title>Determination of fast milk coagulation phenotype and acidification capacity</title>
<p>A volume of 5 mL of the overnight cultures of the LAB strains was centrifuged using an Eppendorf 5804 R centrifuge (Eppendorf, Hamburg, Germany) at 8000&#x00D7;<italic>g</italic> for 10 min at 4 &#x00B0;C. The cells were washed twice with sterile phosphate-buffered saline (PBS, pH=7.4). A volume of 200 &#x00B5;L of each cell suspension was inoculated into 10 % (<italic>m</italic>/<italic>V</italic>) skimmed milk (Sigma-Aldrich, Merck) and incubated at 37 &#x00B0;C for 16 h.</p>
<p>The ability of the LAB to coagulate milk was determined according to Hebert <italic>et al</italic>. (<xref ref-type="bibr" rid="r18"><italic>18</italic></xref>). Depending on the rate of milk coagulation, the results were interpreted as follows: no coagulation, or as low, moderate, good or excellent coagulation.</p>
<p>Acidification capacity was measured in the supernatants by monitoring the pH change with a pH meter (Metrohm, Herisau, Switzerland) and by the titration method with 0.1 M NaOH (Carlo Erba, Milan, Italy) with the addition of phenolphthalein indicator (Kemika, Zagreb, Croatia) until a pink colour appeared. The titratable acidity expressed as &#x00B0;SH (1 &#x00B0;SH=0.0225 % lactic acid) was determined as follows:</p>
<disp-formula id="e"><graphic xlink:href="FTB-64-20-e1.jpg"></graphic> /1/</disp-formula>
<p>where <italic>V</italic> is the volume (in mL) of 0.1 M NaOH and <italic>f</italic><sub>NaOH</sub> is the correction factor of NaOH (1).</p>
</sec>
<sec>
<title>Proteinase plate assay</title>
<p>Mass per volume ratio of 10 % skimmed milk (Sigma-Aldrich, Merck) was used to observe the proteinase phenotype of the strains according to Raveschot <italic>et al</italic>. (<xref ref-type="bibr" rid="r19"><italic>19</italic></xref>) with slight modifications. Solid skimmed milk agar plates were routinely prepared by adding 1 % (<italic>m</italic>/<italic>V</italic>) agar (Biolife) to the medium. After solidification, sterile wells with a diameter of 7 mm were drilled and 50 &#x00B5;L of cell suspension or the supernatant of the overnight grown bacterial culture was added. Transparent halos were an indicator of proteolytic activity.</p>
</sec>
<sec>
<title>Determination of proteolytic activity by Anson&apos;s method</title>
<p>The proteolytic activity of selected LAB strains was determined using the Anson method according to Beganovi&#x0107; <italic>et al</italic>. (<xref ref-type="bibr" rid="r16"><italic>16</italic></xref>). A volume of 1 mL of the supernatant filtrate of the overnight culture of each strain was suspended with 5 mL of a 0.65 % (<italic>m</italic>/<italic>V</italic>) casein solution in PBS (pH=7.2). After a 10-minute incubation at 37 &#x00B0;C, the reaction was halted by adding 5 mL of trichloroacetic acid (Thermo Fischer Scientific, Waltham, MA, USA), which led to precipitation of the non-hydrolysed proteins. After another incubation (30 min, 37 &#x00B0;C) and filtration, 5 mL of 0.4 M Na<sub>2</sub>CO<sub>3</sub> solution (Kemika, Zagreb, Croatia) and 1 mL of Folin-Ciocalteu phenol reagent (Merck, Darmstadt, Germany) were added to 2 mL of filtrate. The sample was incubated again for 30 min at 37 &#x00B0;C and filtered. The absorbance was measured at 670 nm on an LKB 5060-006 microplate reader (LKB Vertriebs GmbH, Vienna, Austria). The blank contained a pre-incubated casein solution to which trichloroacetic acid was added at the beginning of the experiment, followed by the addition of the supernatant and all the procedures described above.</p>
<p>Based on the linear equation, the amount (nmol) of <sc>l</sc>-tyrosine (Merck) released was calculated by measuring the absorbance (<italic>A</italic><sub>670 nm</sub>), resulting from the hydrolysis of casein by proteases in the samples (<xref ref-type="fig" rid="f1">Fig. 1</xref>).</p>
<fig id="f1" position="float" fig-type="figure"><label>Fig. 1</label><caption><p>Standard curve for the measurement of amount of <sc>l</sc>-tyrosine and corresponding linear equation for the determination of proteolytic activity by Anson&apos;s method</p></caption><graphic xlink:href="FTB-64-20-f1"></graphic></fig>
</sec>
<sec>
<title>Analysis of the casein degradation products by Tris-tricine SDS-PAGE</title>
<p>The caseionolytic activity of selected bacterial strains was tested according to El-Ghaish <italic>et al</italic>. (<xref ref-type="bibr" rid="r20"><italic>20</italic></xref>) with modifications. Overnight cultures were centrifuged using an Eppendorf 5804 R centrifuge at 3600&#x00D7;<italic>g</italic> for 10 min and then washed with phosphate buffer (pH=7.4). The resulting biomass was suspended in a 2 % (<italic>m</italic>/<italic>V</italic>) skimmed milk solution (Sigma-Aldrich, Merck) and incubated at 37 &#x00B0;C for 48 h. Casein degradation was then monitored using the Tris-tricine sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) method. A non-inoculated skimmed milk solution was used as a control. The gel for Tris-tricine SDS-PAGE was prepared according to Haider <italic>et al</italic>. (<xref ref-type="bibr" rid="r21"><italic>21</italic></xref>).</p>
</sec>
</sec>
<sec>
<title>Antioxidant activity</title>
<p>Overnight cultures of LAB strains were washed twice in PBS buffer (pH=7.4), after which the cells were mixed with freshly prepared 2,2-diphenyl-1-picrylhydrazyl hydrate (DPPH) (0.2 mM in ethyl alcohol) in a 1:1 ratio and incubated in the dark for 30 min. After incubation, the samples were centrifuged and the absorbance of the supernatant was measured at 517 nm. Ethanol and PBS buffer (pH=7.4) were used as a blank test, and DPPH solution in ethyl alcohol and PBS buffer (pH=7.4) was used as a control. The ability to remove DPPH radicals was calculated according to the following equation (<xref ref-type="bibr" rid="r22"><italic>22</italic></xref>):</p>
<disp-formula id="e___1"><graphic xlink:href="FTB-64-20-e2.jpg"></graphic> /2/</disp-formula>
<p>where DPPH is the percentage of 2,2-diphenyl-1-picrylhydrazyl hydrate, <italic>A</italic><sub>sample</sub> is the absorbance of the sample at 517 nm and <italic>A</italic><sub>control</sub> is the absorbance of the control at 517 nm.</p>
</sec>
<sec>
<title>Freeze-drying</title>
<p>Bacterial cells grown to late exponential phase in the optimal liquid nutrient medium were collected by centrifugation using an Eppendorf 5804 R centrifuge (3600&#x00D7;<italic>g</italic>), washed twice with sterile physiological solution and suspended in phosphate buffer (pH=7). The prepared suspension cells were then frozen overnight at -80 &#x00B0;C and freeze-dried for 24 h in Martin Christ Alpha 1&#x2013;2 LDplus freeze dryer (Osterode, Germany).</p>
</sec>
<sec>
<title>Graphical representation and statistical analysis</title>
<p>The experiments were conducted in triplicate and the results are given as the mean of three independent experiments&#x00B1;standard deviation. All graphs, calculations and statistical analyses were made using GraphPad Prism v. 10.1.1 for Windows (<xref ref-type="bibr" rid="r23"><italic>23</italic></xref>). Ordinary one-way analysis of variance (ANOVA) was performed to calculate the significance of differences among multiple pairs of means in the data group. Differences between groups were considered significant when the p-value was below 0.05.</p>
</sec>
</sec>
<sec sec-type="results|discussion">
<title>RESULTS AND DISCUSSION</title>
<sec>
<title>Functional probiotic properties</title>
<sec>
<title>Antibacterial activity</title>
<p>Isolation of LAB with desired functional properties from human sources is a tantalising approach to select potent probiotics for health-promoting applications (<xref ref-type="bibr" rid="r24"><italic>24</italic></xref>). Selected LAB strains isolated from the human milk of Croatian women were previously identified by 16S RNA and whole genome sequencing, deposited in the NCBI database and characterised as producers of potential biotherapeutic molecules such as S-layer proteins (<italic>L. brevis</italic> MB1, MB2, MB13 and MB20), exopolysaccharides (<italic>L. fermentum</italic> MC1) and plantaricins (<italic>L. plantarum</italic> KR19, MC19 and MB18) (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). These strains showed good survival under simulated gastrointestinal tract conditions, aggregation and adhesion to various epithelial and subepithelial structures of the intestinal tract (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). The aim of this study was therefore to assess the antimicrobial activity of selected LAB strains using the turbidimetric method in an appropriate liquid growth medium. The results were expressed as growth inhibition (%) of the tested bacteria compared to the control growth. The turbidimetric method was chosen due to the higher sensitivity than agar methods and due to the potential application of selected LAB strains isolated from human milk as functional starter cultures or even probiotics in fermented functional products. According to the results, after 24 h of incubation, the strains <italic>L. plantarum</italic> MC19 and <italic>L. fermentum</italic> MC1 showed the strongest (p&lt;0.05) antimicrobial activity against the test microorganisms, while the antagonistic activity against the related LAB strains was depleted. <italic>L. plantarum</italic> MC19 strongly inhibited <italic>S. aureus</italic> ATCC<sup>&#x00AE;</sup>25925<sup>&#x2122;</sup>, <italic>S.</italic> Typhimurium ATCC<sup>&#x00AE;</sup>14028<sup>&#x2122;</sup>, <italic>L. monocytogenes</italic> ATCC<sup>&#x00AE;</sup>19111<sup>&#x2122;</sup> and <italic>E. coli</italic> ATCC<sup>&#x00AE;</sup>25922<sup>&#x2122;</sup> with inhibition rates of more than 80 %. A similar antimicrobial activity was observed for <italic>L. fermentum</italic> MC1, with a significantly higher inhibition against <italic>L. monocytogenes</italic> ATCC<sup>&#x00AE;</sup>19111<sup>&#x2122;</sup> (p=0.004) than strain MC19 (<xref ref-type="fig" rid="f2">Fig. 2a</xref>). A slightly lower, but still very high antimicrobial activity was observed for the strains <italic>L. plantarum</italic> MB18 and KR19 against both the test microorganisms and related LAB strains (<xref ref-type="fig" rid="f2">Fig. 2b</xref>). In contrast, <italic>L. brevis</italic> MB13 showed no activity, while other S-layer expressing strains (<italic>L. brevis</italic> MB1, MB2 and MB20) showed lower activity than other strains tested. The antimicrobial effect of LAB against common foodborne pathogens such as <italic>E</italic>. coli, <italic>L. monocytogenes</italic> and <italic>Salmonella</italic> spp. results from the lowering of the pH of the medium due to the organic acids formed and the activity of synthesised bacteriocins, vitamins, EPSs and other metabolites with proven antimicrobial activity (<xref ref-type="bibr" rid="r25"><italic>25</italic></xref>, <xref ref-type="bibr" rid="r26"><italic>26</italic></xref>). While bacteriocins directly kill competing, closely related bacteria or pathogens or inhibit their growth by various mechanisms such as forming pores in the target cell membrane, disrupting ion gradients or inhibiting cell wall synthesis, S-layer proteins form a crystalline layer that covers the surface of the producing bacteria and contributes to structural integrity, mediates interactions with host tissue and modulates host immune responses (<xref ref-type="bibr" rid="r11"><italic>11</italic></xref>). As a result, S-layers significantly enhance the adhesion of the producer to host cells and prevent pathogen adhesion without having direct bactericidal or bacteriostatic properties. This is probably the reason why S-layer producers have a less potent antimicrobial effect than bacteriocin producers. The <italic>pln</italic> loci of three investigated <italic>L. plantarum</italic> strains were disclosed by the detection of <italic>pln</italic>EF, <italic>pln</italic>A and <italic>pln</italic>J genes responsible for the production of the bacteriocins <italic>Pln</italic>EF and <italic>Pln</italic>A, and the peptide <italic>Pln</italic>J of the plantaricin <italic>Pln</italic>JK, using gene-specific primers (<xref ref-type="bibr" rid="r3"><italic>3</italic></xref>). On the other hand, EPSs have health-promoting and rheological properties in the food, pharmaceutical and nutraceutical industries by exerting antimicrobial, antioxidant, immunomodulatory and many other biological functions. Strain <italic>L. fermentum</italic> MC1 biosynthesises a mixture of three different polymers and harbours the genes involved in EPS production and transport, as well as a gene cluster related to bacteriocin production (<xref ref-type="bibr" rid="r12"><italic>12</italic></xref>), which is a functional property contributing to antimicrobial activity. Strain MC1 also showed excellent adhesion properties, which are important for its probiotic activity. It can therefore be surmised that the strong antimicrobial activity of the plantaricin-producing <italic>L. plantarum</italic> strains and the EPS-producing <italic>L. fermentum</italic> MC1 is due to the biomolecules they produce.</p>
<fig id="f2" position="float" fig-type="figure"><label>Fig. 2</label><caption><p>Antimicrobial activity of lactic acid bacteria (LAB) strains against: a) test microorganisms, and b) related LAB strains tested by the turbidimetric method. Different letters above bars indicate statistically significant difference (p&lt;0.05) between the LAB strains and the same test microorganism, <italic>i.e.</italic> a related LAB strain</p></caption><graphic xlink:href="FTB-64-20-f2"></graphic></fig>
</sec>
<sec>
<title>Screening of proteolytic activity</title>
<p>The main component of human and bovine milk is &#x03B2;-casein, a protein that is a rich source of bioactive and antimicrobial peptides contributing to the endogenous peptidome of milk (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>, <xref ref-type="bibr" rid="r27"><italic>27</italic></xref>). Therefore, bovine skimmed milk was used as a milk model system for the evaluation of proteolytic capacity. Preliminary analyses of the selected autochthonous strains from human milk have shown that their ability to efficiently coagulate milk and exhibit a fast milk coagulation (Fmc) phenotype is a strain-dependent trait (<xref ref-type="fig" rid="f3">Fig. 3a</xref>). <italic>L. plantarum</italic> MB15 showed a low coagulation efficiency, <italic>L. brevis</italic> MB20 a moderate one, the strains <italic>L. plantarum</italic> KR19, <italic>L. plantarum</italic> MB18, <italic>L. brevis</italic> MB13, <italic>L. brevis</italic> MB1 and <italic>L. brevis</italic> MB2 a good one, while the strain <italic>L. fermentum</italic> MC1 showed an excellent coagulation efficiency. Determination of the fast milk acidification rate showed that the strains decreased the pH of the cultivation medium after overnight growth to values between (4.12&#x00B1;0.01) for <italic>L. fermentum</italic> MC1 and (3.81&#x00B1;0.08) for <italic>L. plantarum</italic> MB18, which is consistent with the degree of acidity (<xref ref-type="fig" rid="f3">Fig. 3b</xref>). Cervantes-Elizarrar&#x00E1;s <italic>et al</italic>. (<xref ref-type="bibr" rid="r28"><italic>28</italic></xref>) have reported that organic acids generated by LAB can suppress the growth of Gram-negative bacteria by penetrating their cell membranes and thus impairing their function, leading to acidification of the cytoplasm and inhibition of acid-sensitive enzymes. Although <italic>L. fermentum</italic> MC1 decreased the pH of the medium the least, it exhibited the strongest Fmc+ phenotype as determined by the fastest coagulation rate of the milk. This discrepancy can be explained by the fact that rapid milk coagulation does not necessarily require high acid production, as LAB can possess various traits and mechanisms, such as high enzymatic activity, which allow them to effectively coagulate milk proteins independently of acid production. Presumably, strain MC1 produces proteolytic enzymes that directly cleave milk proteins and cause effective coagulation without significantly lowering the pH of the medium.</p>
<fig id="f3" position="float" fig-type="figure"><label>Fig. 3</label><caption><p>Results of measurements of: a) milk coagulation efficiency, b) pH values and degree of acidity after overnight incubation, and c) proteinase activity of cell-free culture supernatants and concentrated bacterial cell suspensions of <italic>Lactobacillus</italic> strains isolated from human milk. Asterisks indicate significant differences at different levels: *p&lt;0.05, **p&lt;0.01</p></caption><graphic xlink:href="FTB-64-20-f3"></graphic></fig>
<p>Cell-envelope proteinases (CEPs) play a crucial role in the proteolytic system of LAB, as they are required to degrade proteins into peptides and/or amino acids, serving as a nitrogen source for LAB. Therefore, the presence of potential proteinase activity was tested in concentrated bacterial cell suspensions and in cell-free culture supernatants. The result showed that both the strains and their cell-free supernatants were able to hydrolyse the skimmed milk proteins as evident from the appearance of the transparent halos around the wells in the agar, indicating casein hydrolysis (<xref ref-type="fig" rid="f3">Fig. 3c</xref>). The mean diameter of the transparent halos was 10.8&#x00B1;1.2 for the LAB cell suspensions and 10.2&#x00B1;0.7 for the cell-free supernatants, indicating a slightly stronger caseinolytic activity of the LAB cells, albeit without significant meaning (p&gt;0.05). However, the cell suspension of strain <italic>L. brevis</italic> MB20 showed significantly stronger (p=0.036) caseinolytic activity than its cell-free supernatant, suggesting that its proteolytic activity may be due to CEPs. These results are consistent with the research of Novak <italic>et al</italic>. (<xref ref-type="bibr" rid="r6"><italic>6</italic></xref>), in which caseinolytic activity was detected in concentrated cell biomass of lactobacilli and lactococci strains isolated from various autochthonous fermented products.</p>
<p>Representative exopolysaccharide (<italic>L. fermentum</italic> MC1), bacteriocin (<italic>L. plantarum</italic> MB18) and S-protein (<italic>L. brevis</italic> MB1 and <italic>L. brevis</italic> MB2) producers, whose cell-free culture supernatants and concentrated bacterial cell suspensions showed the highest proteinase activity, were further selected for evaluation of casein degradation potential. Human milk contains two classes of proteins, casein and whey proteins (<xref ref-type="bibr" rid="r29"><italic>29</italic></xref>). In this study, the hydrolysis of casein and whey proteins into protein fragments and peptides was studied using Tris-tricine SDS-PAGE (<xref ref-type="fig" rid="f4">Fig. 4a</xref>). This resulted in the appearance of lower-intensity bands, implying that casein and whey proteins were partially degraded, <italic>i.e.</italic> a smaller amount of intact proteins remained. The strain <italic>L. plantarum</italic> MB18 showed the highest proteinase activity, which is consistent with the quantitative analysis of proteinase activities, where the amount of <sc>l</sc>-tyrosine released was (46.0&#x00B1;8.8) nmoL (<xref ref-type="fig" rid="f4">Fig. 4b</xref>). According to the literature, many LAB belonging to the <italic>L. plantarum</italic> strains produce peptides with numerous bioactive effects such as anti-inflammatory, antihaemolytic, antioxidant, antimutagenic or antimicrobial effects through the fermentation of milk (<xref ref-type="bibr" rid="r30"><italic>30</italic></xref>). Since infant formulas are highly rich in casein, which makes them difficult to digest compared to human milk, supplementation with strains expressing active proteinase could eventually contribute to improved casein digestibility (<xref ref-type="bibr" rid="r31"><italic>31</italic></xref>). This feature is attractive from various aspects of the application of <italic>Lactobacillus</italic> strains, whether as a probiotic supplement in cow&apos;s milk-based infant formula or as a starter culture in fermented food products as this can lead to the accumulation of health-promoting bioactive peptides.</p>
<fig id="f4" position="float" fig-type="figure"><label>Fig. 4</label><caption><p>Results of: a) Tris-tricine SDS-PAGE analysis of samples obtained after hydrolysis of skim milk and b) amount (nmol) of <sc>l</sc>-tyrosine released by potential proteolytic activities of selected lactic acid bacteria (LAB) strains determined by the Anson&apos;s method</p></caption><graphic xlink:href="FTB-64-20-f4"></graphic></fig>
</sec>
<sec>
<title>Antioxidant capacity</title>
<p>An imbalance in the body can be caused by oxidative stress, which leads to damage to cells and tissues, triggered by the excessive production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). As a result, various diseases can develop, such as diabetes, cancer, cardiovascular problems and inflammatory and neurological diseases. For this reason, it is necessary to develop supplements with antioxidant effect in order to reduce oxidative stress, and here the potential of probiotics has also gained tremendous scientific importance (<xref ref-type="bibr" rid="r13"><italic>13</italic></xref>, <xref ref-type="bibr" rid="r32"><italic>32</italic></xref>). During food fermentation, the antioxidant activity of LAB can be attributed to bioactive peptides, EPSs, organic acids and a change in the pH of the environment, which can lead to an increase in their bioavailability (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>, <xref ref-type="bibr" rid="r33"><italic>33</italic></xref>).</p>
<p>Therefore, the antioxidant activity of the selected strains was evaluated using DPPH radical scavenging activity. Strain <italic>L. brevis</italic> MB2 showed the highest and strain <italic>L. plantarum</italic> KR19 the lowest radical scavenging activity, while strains MB1, MB13, MB20, MB18, MC1 and MC19 showed similar DPPH radical scavenging activity of about 50 % (<xref ref-type="fig" rid="f5">Fig. 5</xref>). Using the same method, Vougiouklaki <italic>et al</italic>. (<xref ref-type="bibr" rid="r34"><italic>34</italic></xref>) reported that <italic>Lactobacillus gasseri</italic> ATCC 33323 removed 78 % of DPPH radicals, while the values for <italic>Lacticaseibacillus rhamnosus</italic> GG ATCC 53103, <italic>Levilactobacillus brevis</italic> ATCC 8287 and <italic>Lactiplantibacillus plantarum</italic> ATCC 14917 were between 33 and 39 %.</p>
<fig id="f5" position="float" fig-type="figure"><label>Fig. 5</label><caption><p>Antioxidant activity as percentage of DPPH scavenging of selected <italic>Lactobacillus</italic> strains. Asterisks indicate significant differences at different levels: *p&lt;0.05, **p&lt;0.01, ****p&lt;0.0001</p></caption><graphic xlink:href="FTB-64-20-f5"></graphic></fig>
<p>Among all the strains tested, the EPS-producing <italic>L. fermentum</italic> MC1 and the plantaricin-producing <italic>L. plantarum</italic> MB18 strains can find potential application due to their desirable properties. Proteolytic activity is a prerequisite for starter culture application, which can result in production of bioactive peptides with numerous functional properties (<xref ref-type="bibr" rid="r5"><italic>5</italic></xref>). Due to their ability to inhibit the growth of a wide spectrum of bacteria, they can serve as biopreservatives that can extend the shelf life of the consumed product. In addition to antimicrobial properties, antioxidant activity may also be important in extending the shelf life of functional products as well as for protection from oxidative damage in the human body after consumption, along with their functional role, while EPS production can have a positive impact on rheological properties. Overall, all these effects can additionally improve the nutritional relevance of functional products with functional roles for host health, such as gut microbiota balance.</p>
</sec>
</sec>
<sec>
<title>Technological probiotic properties</title>
<p>Drying processes are often used to stabilise probiotic ingredients by reducing their moisture content and facilitating their transport and preservation, with freeze-drying being the most commonly used method. The probiotic powder acquired by freeze-drying can successfully maintain the viability of probiotics and has a satisfactory fermentation performance (<xref ref-type="bibr" rid="r35"><italic>35</italic></xref>). Although cryoprotectants are often used to support the survivability of bacteria, we used only phosphate buffer to investigate the ability of LAB strains isolated from human milk to survive the extreme conditions during freeze-drying. According to the results (<xref ref-type="table" rid="t2">Table 2</xref>), the most remarkable survival rate after freeze-drying was observed in <italic>L. brevis</italic> MB1 and MB20 strains, with a loss of only (1.09&#x00B1;0.02) and (1.00&#x00B1;0.05) log CFU/mL, respectively. On the other hand, <italic>L. plantarum</italic> strains showed a greater loss of viable cells, especially strain <italic>L. plantarum</italic> MC19 with a loss of (4.5&#x00B1;0.1) log CFU/mL, while <italic>L. plantarum</italic> MB18 lost only (1.85&#x00B1;0.01) log CFU/mL. This phenomenon may be due to the expression of S-layer proteins on the cell surface of the <italic>L. brevis</italic> strains, which also showed a protective role in simulated gastrointestinal passage and increased adhesion to the Caco-2 cell line (<xref ref-type="bibr" rid="r10"><italic>10</italic></xref>). All strains, with the exception of <italic>L. plantarum</italic> MC19, excreted more than 10<sup>6</sup> CFU/mL after freeze-drying, which is a generally recognised requirement for probiotics to have a therapeutic effect at the time of consumption (<xref ref-type="bibr" rid="r36"><italic>36</italic></xref>). Overall, all tested strains, with the exception of <italic>L. plantarum</italic> MC19, fulfil the primary technological criterion for selecting probiotic strains.</p>
<table-wrap id="t2" position="float">
<label>Table 2</label><caption><title>The viable cell count of lactic acid bacteria (LAB) strains isolated from human milk before and after freeze-drying in phosphate buffer</title>
</caption>
<table frame="hsides" rules="groups">
<col width="21.49%"/>
<col width="25.47%"/>
<col width="28.88%"/>
<col width="24.16%"/>
<thead>
<tr>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">LAB strain</th>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">Before freeze-drying <italic>N</italic>/(logCFU/mL)</th>
<th valign="middle" align="center" scope="col" style="background-color:rgb(217,217,217)">After freeze-drying <italic>N</italic>/(log CFU/mL)</th>
<th valign="top" align="center" scope="col" style="background-color:rgb(217,217,217)">Freeze-drying survival rate/%</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="justify" scope="row"><italic>L. plantarum</italic> KR19</td>
<td valign="middle" align="center">(9.722&#x00B1;0.003)<sup>a</sup></td>
<td valign="middle" align="center">(6.95&#x00B1;0.03)<sup>b</sup></td>
<td valign="top" align="center">(71.50&#x00B1;0.03)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>L. fermentum</italic> MC1</td>
<td valign="middle" align="center">(9.96&#x00B1;0.07)<sup>a</sup></td>
<td valign="middle" align="center">(7.85&#x00B1;0.08)<sup>b</sup></td>
<td valign="top" align="center">(78.8&#x00B1;0.1)</td>
</tr>
<tr>
<td valign="middle" align="left" scope="row"><italic>L. plantarum</italic> MC19</td>
<td valign="middle" align="center">(9.66&#x00B1;0.02)<sup>a</sup></td>
<td valign="middle" align="center">(5.1&#x00B1;0.11)<sup>b</sup></td>
<td valign="top" align="center">(53.0&#x00B1;0.1)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>L. brevis</italic> MB1</td>
<td valign="middle" align="center">(9.245&#x00B1;0.004)<sup>a</sup></td>
<td valign="middle" align="center">(8.16&#x00B1;0.02)<sup>b</sup></td>
<td valign="top" align="center">(88.25&#x00B1;0.02)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>L. brevis</italic> MB2</td>
<td valign="middle" align="center">(10.228&#x00B1;0.003)<sup>a</sup></td>
<td valign="middle" align="center">(8.27&#x00B1;0.02)<sup>b</sup></td>
<td valign="top" align="center">(80.88&#x00B1;0.02)</td>
</tr>
<tr>
<td valign="middle" align="justify" scope="row"><italic>L. brevis</italic> MB13</td>
<td valign="middle" align="center">(9.67&#x00B1;0.02)<sup>a</sup></td>
<td valign="middle" align="center">(7.995&#x00B1;0.069)<sup>b</sup></td>
<td valign="top" align="center">(82.67&#x00B1;0.07)</td>
</tr>
<tr>
<td valign="middle" align="left" scope="row"><italic>L. plantarum</italic> MB18</td>
<td valign="middle" align="center">(8.86&#x00B1;0.01)<sup>a</sup></td>
<td valign="middle" align="center">(7.003&#x00B1;0.005)<sup>b</sup></td>
<td valign="top" align="center">(79.08&#x00B1;0.01)</td>
</tr>
<tr>
<td valign="middle" align="justify" style="border-bottom: solid 0.50pt" scope="row"><italic>L. brevis</italic> MB20</td>
<td valign="middle" align="center" style="border-bottom: solid 0.50pt">(9.02&#x00B1;0.02)<sup>a</sup></td>
<td valign="middle" align="center" style="border-bottom: solid 0.50pt">(8.01&#x00B1;0.04)<sup>b</sup></td>
<td valign="top" align="center" style="border-bottom: solid 0.50pt">(88.88&#x00B1;0.05)</td>
</tr>
</tbody>
</table><table-wrap-foot>
<p>Results are reported as mean value&#x00B1;standard deviation. Different letters in superscript indicate statistically significant difference (p&lt;0.05) between the same strain before and after freeze-drying</p>
</table-wrap-foot></table-wrap>
</sec>
</sec>
<sec sec-type="conclusions">
<title>CONCLUSIONS</title>
<p>Our data provide interesting insights into the specific probiotic features and potential use of LAB isolated from the human milk microbiota in functional products, especially the exopolysaccharide-producing strain <italic>Limosilactobacillus fermentum</italic> MC1 and the plantaricin-producing <italic>Lactiplantibacillus plantarum</italic> MB18. The beneficial properties of these cultures, exerted through functional, technological and safety criteria, may be useful for the production of fermented products with added functional value and with potential nutritional and functional relevance for the host. Their potential application may focus on their use as bio-preservatives to reduce the use of chemical additives, which meets consumer demand for more natural and environmentally friendly products.</p>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>This paper is dedicated to our dear colleague, Professor Emeritus Vladimir Mr&#x0161;a, with whom we had the privilege of collaborating successfully throughout his distinguished scientific and academic career.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p content-type="fn-title">FUNDING</p>
<p>This work was funded by the Croatian Science Foundation through the projects IP-2014-09-7009, IP-2019-04-2237 and IP-2024-05-6548. The authors also gratefully acknowledge the financial assistance of the University of Zagreb, Croatia, as well as the equipment provided through the financial backing of the project &#x201C;Bioprospecting of the Adriatic Sea&#x201D; (KK.01.1.1.01.0002), granted to the Scientific Centre of Excellence for Marine Bioprospecting (BioProCro) at the Ru&#x0111;er Bo&#x0161;kovi&#x0107; Institute, Zagreb, Croatia.</p>
</fn>
<fn fn-type="conflict">
<p content-type="fn-title">CONFLICT OF INTEREST</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>REFERENCES</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinson</surname><given-names>LF</given-names></name><name><surname>Sindi</surname><given-names>AS</given-names></name><name><surname>Cheema</surname><given-names>AS</given-names></name><name><surname>Lai</surname><given-names>CT</given-names></name><name><surname>M&#x00FC;hlh&#x00E4;usler</surname><given-names>BS</given-names></name><name><surname>Wlodek</surname><given-names>ME</given-names></name><etal/></person-group> <article-title>The human milk microbiome: who, what, when, where, why, and how?</article-title> <source>Nutr Rev</source>. <year>2021</year>;<volume>79</volume>(<issue>5</issue>):<fpage>529</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1093/nutrit/nuaa029</pub-id><pub-id pub-id-type="pmid">32443154</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Duo</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Characterization of potentially probiotic lactic acid bacteria and bifidobacteria isolated from human colostrum.</article-title> <source>J Dairy Sci</source>. <year>2020</year>;<volume>103</volume>(<issue>5</issue>):<fpage>4013</fpage>&#x2013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2019-17602</pub-id><pub-id pub-id-type="pmid">32113772</pub-id></mixed-citation></ref>
<ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bani&#x0107;</surname><given-names>M</given-names></name><name><surname>Butorac</surname><given-names>K</given-names></name><name><surname>&#x010C;uljak</surname><given-names>N</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Bellich</surname><given-names>B</given-names></name><etal/></person-group> <article-title>The human milk microbiota produces potential therapeutic biomolecules and shapes the intestinal microbiota of infants.</article-title> <source>Int J Mol Sci</source>. <year>2022</year>;<volume>23</volume>(<issue>22</issue>):<fpage>14382</fpage>. <pub-id pub-id-type="doi">10.3390/ijms232214382</pub-id><pub-id pub-id-type="pmid">36430861</pub-id></mixed-citation></ref>
<ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>P</given-names></name><name><surname>Curtis</surname><given-names>N</given-names></name></person-group>. <article-title>Breast milk microbiota: A review of the factors that influence composition.</article-title> <source>J Infect</source>. <year>2020</year>;<volume>81</volume>(<issue>1</issue>):<fpage>17</fpage>&#x2013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.01.023</pub-id><pub-id pub-id-type="pmid">32035939</pub-id></mixed-citation></ref>
<ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bani&#x0107;</surname><given-names>M</given-names></name><name><surname>Butorac</surname><given-names>K</given-names></name><name><surname>&#x010C;uljak</surname><given-names>N</given-names></name><name><surname>Butorac</surname><given-names>A</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><etal/></person-group> <article-title>An integrated comprehensive peptidomics and <italic>in silico</italic> analysis of bioactive peptide-rich milk fermented by three autochthonous cocci strains.</article-title> <source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>(<issue>4</issue>):<fpage>2431</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25042431</pub-id><pub-id pub-id-type="pmid">38397111</pub-id></mixed-citation></ref>
<ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Butorac</surname><given-names>K</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>Bani&#x0107;</surname><given-names>M</given-names></name><name><surname>Butorac</surname><given-names>A</given-names></name><name><surname>Lepur</surname><given-names>A</given-names></name><etal/></person-group> <article-title>A lactic acid bacteria consortium impacted the content of casein-derived biopeptides in dried fresh cheese.</article-title> <source>Molecules</source>. <year>2022</year>;<volume>27</volume>(<issue>1</issue>):<fpage>160</fpage>. <pub-id pub-id-type="doi">10.3390/molecules27010160</pub-id><pub-id pub-id-type="pmid">35011392</pub-id></mixed-citation></ref>
<ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muhammad</surname><given-names>Z</given-names></name><name><surname>Ramzan</surname><given-names>R</given-names></name><name><surname>Abdelazez</surname><given-names>A</given-names></name><name><surname>Amjad</surname><given-names>A</given-names></name><name><surname>Afzaal</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group> <article-title>Assessment of the antimicrobial potentiality and functionality of <italic>Lactobacillus plantarum</italic> strains isolated from the conventional inner Mongolian fermented cheese against foodborne pathogens.</article-title> <source>Pathogens</source>. <year>2019</year>;<volume>8</volume>(<issue>2</issue>):<fpage>71</fpage>. <pub-id pub-id-type="doi">10.3390/pathogens8020071</pub-id><pub-id pub-id-type="pmid">31117307</pub-id></mixed-citation></ref>
<ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oguntoyinbo</surname><given-names>FA</given-names></name><name><surname>Narbad</surname><given-names>A</given-names></name></person-group>. <article-title>Multifunctional properties of <italic>Lactobacillus plantarum</italic> strains isolated from fermented cereal foods.</article-title> <source>J Funct Foods</source>. <year>2015</year>;<volume>17</volume>:<fpage>621</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.jff.2015.06.022</pub-id></mixed-citation></ref>
<ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butorac</surname><given-names>K</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Bani&#x0107;</surname><given-names>M</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>&#x010C;uljak</surname><given-names>N</given-names></name><name><surname>Or&#x0161;oli&#x0107;</surname><given-names>N</given-names></name><etal/></person-group> <article-title>Modulation of the gut microbiota by the plantaricin-producing <italic>Lactiplantibacillus plantarum</italic> D13, analysed in the DSS-induced colitis mouse model.</article-title> <source>Int J Mol Sci</source>. <year>2023</year>;<volume>24</volume>(<issue>20</issue>):<fpage>15322</fpage>. <pub-id pub-id-type="doi">10.3390/ijms242015322</pub-id><pub-id pub-id-type="pmid">37895001</pub-id></mixed-citation></ref>
<ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al Kassaa</surname><given-names>I</given-names></name><name><surname>Hamze</surname><given-names>M</given-names></name><name><surname>Hober</surname><given-names>D</given-names></name><name><surname>Chihib</surname><given-names>NE</given-names></name><name><surname>Drider</surname><given-names>D</given-names></name></person-group>. <article-title>Identification of vaginal Lactobacilli with potential probiotic properties isolated from women in North Lebanon.</article-title> <source>Microb Ecol</source>. <year>2014</year>;<volume>67</volume>(<issue>3</issue>):<fpage>722</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1007/s00248-014-0384-7</pub-id><pub-id pub-id-type="pmid">24549747</pub-id></mixed-citation></ref>
<ref id="r11"><label>11</label><mixed-citation publication-type="thesis">Bani&#x0107; M. Potencijalne terapijske biomolekule probioti&#x010D;kih sojeva autohtonih bakterija mlije&#x010D;ne kiseline (Potential therapeutic biomolecules of probiotic strains of indigenous lactic acid bacteria) [PhD Thesis]. Zagreb, Croatia: University of Zagreb; 2021 (in Croatian).</mixed-citation></ref>
<ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x010C;uljak</surname><given-names>N</given-names></name><name><surname>Bellich</surname><given-names>B</given-names></name><name><surname>Pedron</surname><given-names>A</given-names></name><name><surname>Butorac</surname><given-names>K</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><etal/></person-group> <article-title><italic>Limosilactobacillus fermentum</italic> strains MC1 and D12: Functional properties and exopolysaccharides characterization.</article-title> <source>Int J Biol Macromol</source>. <year>2024</year>;<volume>273</volume>(<issue>Pt 2</issue>):<elocation-id>133215</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.133215</pub-id><pub-id pub-id-type="pmid">38897515</pub-id></mixed-citation></ref>
<ref id="r13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>JE</given-names></name><name><surname>Paek</surname><given-names>NS</given-names></name><etal/></person-group> <article-title>Antioxidant and probiotic properties of lactobacilli and bifidobacteria of human origins.</article-title> <source>Biotechnol Bioprocess Eng</source>. <year>2020</year>;<volume>25</volume>:<fpage>421</fpage>&#x2013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1007/s12257-020-0147-x</pub-id></mixed-citation></ref>
<ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vijayalakshmi</surname><given-names>S</given-names></name><name><surname>Adeyemi</surname><given-names>DE</given-names></name><name><surname>Choi</surname><given-names>IY</given-names></name><name><surname>Sultan</surname><given-names>G</given-names></name><name><surname>Madar</surname><given-names>IH</given-names></name><name><surname>Park</surname><given-names>MK</given-names></name></person-group>. <article-title>Comprehensive <italic>in silico</italic> analysis of lactic acid bacteria for the selection of desirable probiotics.</article-title> <source>LWT &#x2013; Food Sci Technol</source>. <year>2020</year>;<volume>130</volume>:<elocation-id>109617</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.lwt.2020.109617</pub-id></mixed-citation></ref>
<ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenster</surname><given-names>K</given-names></name><name><surname>Freeburg</surname><given-names>B</given-names></name><name><surname>Hollard</surname><given-names>C</given-names></name><name><surname>Wong</surname><given-names>C</given-names></name><name><surname>R&#x00F8;nhave Laursen</surname><given-names>R</given-names></name><name><surname>Ouwehand</surname><given-names>AC</given-names></name></person-group>. <article-title>The production and delivery of probiotics: A review of a practical approach.</article-title> <source>Microorganisms</source>. <year>2019</year>;<volume>7</volume>(<issue>3</issue>):<fpage>83</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms7030083</pub-id><pub-id pub-id-type="pmid">30884906</pub-id></mixed-citation></ref>
<ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beganovi&#x0107;</surname><given-names>J</given-names></name><name><surname>Kos</surname><given-names>B</given-names></name><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>Uroi&#x0107;</surname><given-names>K</given-names></name><name><surname>D&#x017E;idara</surname><given-names>P</given-names></name><name><surname>&#x0160;u&#x0161;kovi&#x0107;</surname><given-names>J</given-names></name></person-group>. <article-title>Proteolytic activity of probiotic strain <italic>Lactobacillus helveticus</italic> M92.</article-title> <source>Anaerobe</source>. <year>2013</year>;<volume>20</volume>:<fpage>58</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.02.004</pub-id><pub-id pub-id-type="pmid">23454496</pub-id></mixed-citation></ref>
<ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebo&#x0161; Pavunc</surname><given-names>A</given-names></name><name><surname>Penava</surname><given-names>L</given-names></name><name><surname>&#x010C;uljak</surname><given-names>N</given-names></name><name><surname>Bani&#x0107;</surname><given-names>M</given-names></name><name><surname>Novak</surname><given-names>J</given-names></name><name><surname>Butorac</surname><given-names>K</given-names></name><etal/></person-group> <article-title>Evaluation of the probiotic properties of <italic>Lacticaseibacillus casei</italic> 431<sup>&#x00AE;</sup> isolated from food for special medical purposes.</article-title> <source>Food Technol Biotechnol</source>. <year>2023</year>;<volume>61</volume>(<issue>4</issue>):<fpage>418</fpage>&#x2013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.17113/ftb.61.04.23.8045</pub-id><pub-id pub-id-type="pmid">38205053</pub-id></mixed-citation></ref>
<ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert</surname><given-names>EM</given-names></name><name><surname>De Giori</surname><given-names>GS</given-names></name><name><surname>Raya</surname><given-names>RR</given-names></name></person-group>. <article-title>Isolation and characterization of a slowly milk-coagulating variant of <italic>Lactobacillus helveticus</italic> deficient in purine biosynthesis.</article-title> <source>Appl Environ Microbiol</source>. <year>2001</year>;<volume>67</volume>(<issue>4</issue>):<fpage>1846</fpage>&#x2013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.67.4.1846-1850.2001</pub-id><pub-id pub-id-type="pmid">11282642</pub-id></mixed-citation></ref>
<ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raveschot</surname><given-names>C</given-names></name><name><surname>Cudennec</surname><given-names>B</given-names></name><name><surname>Coutte</surname><given-names>F</given-names></name><name><surname>Flahaut</surname><given-names>C</given-names></name><name><surname>Fremont</surname><given-names>M</given-names></name><name><surname>Drider</surname><given-names>D</given-names></name><etal/></person-group> <article-title>Production of bioactive peptides by <italic>Lactobacillus</italic> species: From gene to application.</article-title> <source>Front Microbiol</source>. <year>2018</year>;<volume>9</volume>:<fpage>2354</fpage>. <pub-id pub-id-type="doi">10.3389/fmicb.2018.02354</pub-id><pub-id pub-id-type="pmid">30386307</pub-id></mixed-citation></ref>
<ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Ghaish</surname><given-names>S</given-names></name><name><surname>Dalgalarrondo</surname><given-names>M</given-names></name><name><surname>Choiset</surname><given-names>Y</given-names></name><name><surname>Sitohy</surname><given-names>M</given-names></name><name><surname>Ivanova</surname><given-names>I</given-names></name><name><surname>Haertl&#x00E9;</surname><given-names>T</given-names></name><etal/></person-group> <article-title>Screening of strains of <italic>Lactococci</italic> isolated from Egyptian dairy products for their proteolytic activity.</article-title> <source>Food Chem</source>. <year>2010</year>;<volume>120</volume>(<issue>3</issue>):<fpage>758</fpage>&#x2013;<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2009.11.007</pub-id></mixed-citation></ref>
<ref id="r21"><label>21</label><mixed-citation publication-type="book">Haider SR, Reid HJ, Sharp BL. Tricine-SDS-PAGE. In: Kurien BT, Scofield RH, editors. Protein electrophoresis. Methods and protocols. New York, NY, USA: Humana Press; 2012. pp. 81-91. <pub-id pub-id-type="doi">10.1007/978-1-61779-821-4_8</pub-id></mixed-citation></ref>
<ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Son</surname><given-names>SH</given-names></name><name><surname>Yang</surname><given-names>SJ</given-names></name><name><surname>Jeon</surname><given-names>HL</given-names></name><name><surname>Yu</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>NK</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><etal/></person-group> <article-title>Antioxidant and immunostimulatory effect of potential probiotic <italic>Lactobacillus paraplantarum</italic> SC61 isolated from Korean traditional fermented food, jangajji.</article-title> <source>Microb Pathog</source>. <year>2018</year>;<volume>125</volume>:<fpage>486</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.micpath.2018.10.018</pub-id><pub-id pub-id-type="pmid">30342080</pub-id></mixed-citation></ref>
<ref id="r23"><label>23</label><mixed-citation publication-type="web">GraphPad Prism, v. 10.1.1, GraphPad Software Inc, Boston, MA, USA; 2023. Available from: <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>.</mixed-citation></ref>
<ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riaz Rajoka</surname><given-names>MS</given-names></name><name><surname>Mehwish</surname><given-names>HM</given-names></name><name><surname>Siddiq</surname><given-names>M</given-names></name><name><surname>Haobin</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Identification, characterization, and probiotic potential of <italic>Lactobacillus rhamnosus</italic> isolated from human milk.</article-title> <source>LWT &#x2013; Food Sci Technol</source>. <year>2017</year>;<volume>84</volume>:<fpage>271</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.lwt.2017.05.055</pub-id></mixed-citation></ref>
<ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>SA</given-names></name><name><surname>Ayivi</surname><given-names>RD</given-names></name><name><surname>Zimmerman</surname><given-names>T</given-names></name><name><surname>Siddiqui</surname><given-names>SA</given-names></name><name><surname>Altemimi</surname><given-names>AB</given-names></name><name><surname>Fidan</surname><given-names>H</given-names></name><etal/></person-group> <article-title>Lactic acid bacteria as antimicrobial agents: Food safety and microbial food spoilage prevention.</article-title> <source>Foods</source>. <year>2021</year>;<volume>10</volume>(<issue>12</issue>):<fpage>3131</fpage>. <pub-id pub-id-type="doi">10.3390/foods10123131</pub-id><pub-id pub-id-type="pmid">34945682</pub-id></mixed-citation></ref>
<ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zapa&#x015B;nik</surname><given-names>A</given-names></name><name><surname>Soko&#x0142;owska</surname><given-names>B</given-names></name><name><surname>Bry&#x0142;a</surname><given-names>M</given-names></name></person-group>. <article-title>Role of lactic acid bacteria in food preservation and safety.</article-title> <source>Foods</source>. <year>2022</year>;<volume>11</volume>(<issue>9</issue>):<fpage>1283</fpage>. <pub-id pub-id-type="doi">10.3390/foods11091283</pub-id><pub-id pub-id-type="pmid">35564005</pub-id></mixed-citation></ref>
<ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dingess</surname><given-names>KA</given-names></name><name><surname>Gazi</surname><given-names>I</given-names></name><name><surname>van den Toorn</surname><given-names>HWP</given-names></name><name><surname>Mank</surname><given-names>M</given-names></name><name><surname>Stahl</surname><given-names>B</given-names></name><name><surname>Reiding</surname><given-names>KR</given-names></name><etal/></person-group> <article-title>Monitoring human milk &#x03B2;-casein phosphorylation and o-glycosylation over lactation reveals distinct differences between the proteome and endogenous peptidome.</article-title> <source>Int J Mol Sci</source>. <year>2021</year>;<volume>22</volume>(<issue>15</issue>):<fpage>8140</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22158140</pub-id><pub-id pub-id-type="pmid">34360914</pub-id></mixed-citation></ref>
<ref id="r28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervantes-Elizarrar&#x00E1;s</surname><given-names>A</given-names></name><name><surname>Cruz-Cansino</surname><given-names>NS</given-names></name><name><surname>Ram&#x00ED;rez-Moreno</surname><given-names>E</given-names></name><name><surname>Vega-S&#x00E1;nchez</surname><given-names>V</given-names></name><name><surname>Vel&#x00E1;zquez-Guadarrama</surname><given-names>N</given-names></name><name><surname>Zafra-Rojas</surname><given-names>QY</given-names></name><etal/></person-group> <article-title><italic>In vitro</italic> probiotic potential of lactic acid bacteria isolated from aguamiel and pulque and antibacterial activity against pathogens.</article-title> <source>Appl Sci</source>. <year>2019</year>;<volume>9</volume>(<issue>3</issue>):<fpage>601</fpage>. <pub-id pub-id-type="doi">10.3390/app9030601</pub-id></mixed-citation></ref>
<ref id="r29"><label>29</label><mixed-citation publication-type="book">Jiang SL, Guo MR. Processing technology for infant formula. In: Guo M, editor. Human milk biochemistry and infant formula manufacturing technology. Cambridge, MA, USA: Woodhead Publishing; 2020. pp. 223-40. <pub-id pub-id-type="doi">10.1016/B978-0-08-102898-8.00008-8</pub-id></mixed-citation></ref>
<ref id="r30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilar-Toal&#x00E1;</surname><given-names>JE</given-names></name><name><surname>Santiago-L&#x00F3;pez</surname><given-names>L</given-names></name><name><surname>Peres</surname><given-names>CM</given-names></name><name><surname>Peres</surname><given-names>C</given-names></name><name><surname>Garcia</surname><given-names>HS</given-names></name><name><surname>Vallejo-Cordoba</surname><given-names>B</given-names></name><etal/></person-group> <article-title>Assessment of multifunctional activity of bioactive peptides derived from fermented milk by specific <italic>Lactobacillus plantarum</italic> strains.</article-title> <source>J Dairy Sci</source>. <year>2017</year>;<volume>100</volume>(<issue>1</issue>):<fpage>65</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2016-11846</pub-id><pub-id pub-id-type="pmid">27865495</pub-id></mixed-citation></ref>
<ref id="r31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Adelman</surname><given-names>AS</given-names></name><name><surname>Rai</surname><given-names>D</given-names></name><name><surname>Boettcher</surname><given-names>J</given-names></name><name><surname>Lonnerdal</surname><given-names>B</given-names></name></person-group>. <article-title>Amino acid profiles in term and preterm human milk through lactation: A systemic review.</article-title> <source>Nutrients</source>. <year>2013</year>;<volume>5</volume>(<issue>12</issue>):<fpage>4800</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.3390/nu5124800</pub-id><pub-id pub-id-type="pmid">24288022</pub-id></mixed-citation></ref>
<ref id="r32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Jeong</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>CH</given-names></name></person-group>. <article-title>Antioxidant activity and probiotic properties of lactic acid bacteria.</article-title> <source>Fermentation</source>. <year>2022</year>;<volume>8</volume>(<issue>1</issue>):<fpage>29</fpage>. <pub-id pub-id-type="doi">10.3390/fermentation8010029</pub-id></mixed-citation></ref>
<ref id="r33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fadlillah</surname><given-names>HN</given-names></name><name><surname>Nuraida</surname><given-names>L</given-names></name><name><surname>Sitanggang</surname><given-names>AB</given-names></name><name><surname>Palupi</surname><given-names>NS</given-names></name></person-group>. <article-title>Production of antioxidants through lactic acid fermentation: Current developments and outlook.</article-title> <source>Ann U Dunarea-Food</source>. <year>2021</year>;<volume>45</volume>(<issue>2</issue>):<fpage>203</fpage>&#x2013;<lpage>28</lpage>. <pub-id pub-id-type="doi">10.35219/foodtechnology.2021.2.13</pub-id></mixed-citation></ref>
<ref id="r34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vougiouklaki</surname><given-names>D</given-names></name><name><surname>Tsironi</surname><given-names>T</given-names></name><name><surname>Tsantes</surname><given-names>AG</given-names></name><name><surname>Tsakali</surname><given-names>E</given-names></name><name><surname>Van Impe</surname><given-names>JFM</given-names></name><name><surname>Houhoula</surname><given-names>D</given-names></name></person-group>. <article-title>Probiotic properties and antioxidant activity <italic>in vitro</italic> of lactic acid bacteria.</article-title> <source>Microorganisms</source>. <year>2023</year>;<volume>11</volume>(<issue>5</issue>):<fpage>1264</fpage>. <pub-id pub-id-type="doi">10.3390/microorganisms11051264</pub-id><pub-id pub-id-type="pmid">37317238</pub-id></mixed-citation></ref>
<ref id="r35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Ye</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Gu</surname><given-names>Q</given-names></name></person-group>. <article-title>Research progress on improving the freeze-drying resistance of probiotics: A review.</article-title> <source>Trends Food Sci Technol</source>. <year>2024</year>;<volume>147</volume>:<elocation-id>104425</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.tifs.2024.104425</pub-id></mixed-citation></ref>
<ref id="r36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nyanzi</surname><given-names>R</given-names></name><name><surname>Piet</surname><given-names>JJ</given-names></name><name><surname>Buys</surname><given-names>EM</given-names></name></person-group>. <article-title>Invited review: Probiotic yogurt quality criteria, regulatory framework, clinical evidence, and analytical aspects.</article-title> <source>J Dairy Sci</source>. <year>2021</year>;<volume>104</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.3168/jds.2020-19116</pub-id><pub-id pub-id-type="pmid">33348476</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
